New SEC Form D filing

Auron Therapeutics, Inc., 2026-08-13

A new SEC Form D private-offering notice from Wellesley, MA, a $12,000,000 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Auron Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical-stage biotech developing differentiation therapies for cancer using an AI driven single-cell genomics platform

Filed 6 days agoFiled to raise $12,000,000First money in 2026-08-10Raised so far $7,118,141HQ (as filed) Wellesley, MASector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Debt-only offering
Source linked the Form D on EDGAR↗Website verified aurontx.com↗Named in the filing 7 executives & directors
Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source